Robert Wesolowski, MD
College of Medicine
Breast Cancer, Cancer, Hypersensitivity, Carcinoma, Hepatocellular, Carcinoma, Sarcoma, Neutropenia, Neoplasm Metastasis, Stomach Cancer, Prostatic Cancer
Dr. Wesolowski's research interests include breast cancer immunology, in particular myeloid-derived suppressor cells (MDSC) and early phase trials of experimental therapeutics. MDSC are important inhibitors of anti-tumor immune response. He studying using MDSC as biomarkers of response to neoadjuvant chemotherapy and recently received a grant supporting this work. He also coordinates phase I solid tumor trials for the Division of Oncology, serves as local principal investigator on several phase I trials and is a member of the Precision Medicine Clinic where cancer patients will have their tumor DNA sequenced to identify cancers with gene mutations that have commercially available drugs that target these gene mutations. Dr. Wesolowski provides clinical care to women with all stages of invasive breast cancer and sees phase I patients in the Precision Medicine Clinic.